Biogen buys a brain disorder drug for $217 million, but needs to go bigger, analyst says

Article Link: Biogen buys a brain disorder drug for 7 million, but needs to go bigger, analyst says

Biogen reported fourth-quarter revenue of $3.31 billion, above the $3.1 billion expected from analysts polled by Thomson Reuters.

Source: CNN Investing